Specialty medication

Ended Awarded Last action

Contract number
36C26222F0185
Awardee
Awarding agency
Obligated
$342,951

Award facts

Contract value 98% obligated
$351,244.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bartlett, TN 38134, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 -$8,294
Original award $351,244

About this award

This is a $351,244.44 firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a large pharmaceutical manufacturer. The order is for specialty medication, primarily treatments for pulmonary arterial hypertension, which are critical drugs for VA medical centers and other federal healthcare facilities. The contract is placed against Actelion's $105 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), allowing the VA to procure these medications at pre-negotiated prices. Actelion also holds a $60 million Blanket Purchase Agreement (BPA) with the VA specifically for pulmonary arterial hypertension therapies, as well as a newer $83.5 million single-award BPA covering these and additional specialized drugs. This delivery order is not a small business set-aside.

Quick answers

Who was awarded contract 36C26222F0185?

36C26222F0185 was awarded to Actelion Pharmaceuticals US, Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on February 4, 2022.

How much is contract 36C26222F0185 worth?

The government has obligated $342,951 on 36C26222F0185. Its current value, with exercised options, is $351,244.

Is contract 36C26222F0185 an order under another contract?

Yes. 36C26222F0185 is a delivery order under 36F79719D0142, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26222F0185 competed?

The extent of competition for 36C26222F0185 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award